|
Practice A
| | | | | | | | |
| Patients in age group, n
| 4006 | 1729 | 1735 | 2404 | 1772 | 1524 | 902 | 283 |
| % of all patients in age group | 28 | 12 | 12 | 17 | 12 | 11 | 6 | 2 |
| Long-term high dose users, n
| 0 | 1 | 2 | 7 | 5 | 3 | 5 | 2 |
|
n/1000 patients | 0 | 0.58 | 1.15 | 2.91 | 2.82 | 1.97 | 5.54 | 7.07 |
|
Practice B
| | | | | | | | |
| Patients in age group, n
| 2632 | 1170 | 1119 | 1236 | 972 | 836 | 410 | 106 |
| % of all patients in age group | 31 | 14 | 13 | 15 | 11 | 10 | 5 | 1 |
| Long-term high dose users, n
| 0 | 2 | 4 | 3 | 3 | 0 | 3 | 0 |
|
n/1000 patients | 0 | 1.71 | 3.57 | 2.43 | 3.09 | 0 | 7.32 | 0 |
|
Combined
| | | | | | | | |
| Patients in age group, n
| 6638 | 2899 | 2854 | 3640 | 2744 | 2360 | 1312 | 389 |
| % of all patients in age group | 29 | 13 | 12 | 16 | 12 | 10 | 6 | 2 |
| Long-term high dose users, n
| 0 | 3 | 6 | 10 | 8 | 3 | 8 | 2 |
|
n/1000 patients | 0 | 1.03 | 2.10 | 2.75 | 2.91 | 1.27 | 6.10 | 5.14 |